FIELD: medicine, chemistry of peptides, amino acids.
SUBSTANCE: invention relates to novel biologically active substances. Invention proposes the novel composition comprising peptides of the formula: H-Arg-Gly-Asp-OH and H-Tyr-X-Y-Glu-OH wherein X means Gln and/or Glu; Y means Cys(acm) and/or Cys. The composition shows ability to inhibit proliferative activity of mononuclear cells, to induce suppressive activity and their ability for secretion of cytokines TNF-1β (tumor necrosis factor-1β) and IL-10 (interleukin-10 ).
EFFECT: simplified method for preparing composition, valuable medicinal properties of composition.
4 cl, 16 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE COMPOSITION ELICITING IMMUNITY REGULATING PROPERTY | 2003 |
|
RU2244719C1 |
| PEPTIDE WITH IMMUNOREGULATING PROPERTY AND COMPOSITION BASED ON THEREOF | 2002 |
|
RU2210382C1 |
| AGENT POSSESSING IMMUNOREGULATORY PROPERTY AND ITS USING IN TREATMENT OF AUTOIMMUNE DISEASES | 2006 |
|
RU2303995C1 |
| AGENT FOR TREATING AUTOIMMUNE DISEASES | 2013 |
|
RU2528337C1 |
| AGENT FOR TREATMENT OF AUTOIMMUNE DISEASES WITH SUPPRESSOR IMMUNODEFICIENCY AND A METHOD OF AUTOIMMUNE DISEASES TREATMENT | 1994 |
|
RU2056852C1 |
| PHARMACEUTICAL COMPOSITION OF THE FUSION PROTEIN OF THE TRANSFORMING GROWTH FACTOR BETA RECEPTOR AND ITS APPLICATION | 2019 |
|
RU2791683C2 |
| FUSED PROTEIN CONTAINING TGF-BETA RECEPTOR, AND ITS PHARMACEUTICAL USE | 2018 |
|
RU2776204C1 |
| SYNTHETIC ANTIGEN ABILITY TO BIND β-ADRENORECEPTOR AUTOANTIBODIES | 2007 |
|
RU2356576C1 |
| MONOCLONAL ANTIBODY SUPPRESSING THE IMMUNOSUPPRESSIVE FUNCTIONS OF PATHOGENS, ANTIGEN-BINDING FRAGMENT OF THE SPECIFIED ANTIBODY AND HYBRIDOMAS PRODUCING THE SPECIFIED ANTIBODY | 2017 |
|
RU2751918C2 |
| ANTI-OX40 ANTIBODIES AND THEIR APPLICATION | 2017 |
|
RU2753493C2 |
